federal_register: 2020-01072

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2020-01072 Product-Specific Guidance for Levonorgestrel; Intrauterine Device; Revised Draft Guidance for Industry; Availability Notice The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a revised draft guidance for industry, entitled "Draft Guidance for Levonorgestrel." The revised draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for a levonorgestrel intrauterine device. 2020-01-23 2020 1 https://www.federalregister.gov/documents/2020/01/23/2020-01072/product-specific-guidance-for-levonorgestrel-intrauterine-device-revised-draft-guidance-for-industry https://www.govinfo.gov/content/pkg/FR-2020-01-23/pdf/2020-01072.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a revised draft guidance for industry, entitled "Draft Guidance for Levonorgestrel." The revised draft guidance, when finalized, will provide product-specific...

Links from other tables